Mr. Rogers joined the Board in April 2016 bringing to Keryx more than 25 years of financial leadership in the biotech industry. He currently serves as the chief financial officer of Acorda Therapeutics. Prior to joining Acorda, he served as chief financial officer of four additional healthcare companies BG Medicine, Inc., Indevus Pharmaceuticals, Inc., Advanced Health Corporation and Autoimmune Inc. Prior to his roles as CFO, Mr. Rogers was an investment banker at Lehman Brothers and PaineWebber, where he focused on life sciences companies. Mr. Rogers received his B.A. from Union College and an M.B.A. from the Darden School of Business at the University of Virginia. He currently serves on the Board of Directors for pSivida Corp.